Target intelligence / Profile preview

Anaphase-promoting complex subunit 13 (ANAPC13)

Target
ANAPC13
Molecular classification
Other (APC/C subunit; not a typical receptor, enzyme, transporter, or known therapeutic target class)
01

Overview

Anaphase-promoting complex subunit 13 (ANAPC13) is a highly conserved, small protein subunit of the anaphase-promoting complex/cyclosome (APC/C), a large multi-subunit E3 ubiquitin ligase essential for regulating cell cycle progression via targeted degradation of key cell cycle proteins, such as securin and B-type cyclins[1][3][5]. ANAPC13 is critical for APC/C structural integrity and function, facilitating the timely execution of APC/C-dependent cell cycle events, particularly during mitosis and G1 phase[1][5]. Disruption of ANAPC13 or its regulatory functions has been linked to malignant progression in several cancers, including breast and liver cancer, mainly due to its role in maintaining genomic stability[3][5]. No approved or investigational drugs are currently known to target ANAPC13 specifically, as it serves as a part of a larger complex rather than as a standalone therapeutic target.

Other names
Anaphase-promoting complex subunit 13ANAPC13APC13SWM1DKFZP566D193Cyclosome subunit 13
02

Biological functions

Cell cycle regulationUbiquitin-protein ligase complex componentMitotic progression
03

Disease associations

Cancer (implicated in tumorigenesis and genomic stability)Other (dysregulation may affect cell proliferation and oncogenesis)
04

Biomarkers

ANAPC13 expression (proposed as a potential biomarker in cancer progression, e.g., breast ductal carcinoma)[3]

Beyond the preview

Go deeper on Anaphase-promoting complex subunit 13 (ANAPC13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anaphase-promoting complex subunit 13 (ANAPC13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call